171 related articles for article (PubMed ID: 33889307)
1. High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
Andersson A; Enblad G; Erlanson M; Johansson AS; Molin D; Tavelin B; Näslund U; Melin B
Ups J Med Sci; 2021; 126():. PubMed ID: 33889307
[TBL] [Abstract][Full Text] [Related]
2. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors--retrospective cohort analyses and a concept for prospective intervention.
Andersson A; Näslund U; Tavelin B; Enblad G; Gustavsson A; Malmer B
Int J Cancer; 2009 Apr; 124(8):1914-7. PubMed ID: 19165857
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors.
Lammers EMJ; Nijdam A; Zijlstra JM; Janus CPM; de Weijer RJ; Appelman Y; Manintveld OC; Teske AJ; van Leeuwen FE; Aleman BMP
J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38649650
[TBL] [Abstract][Full Text] [Related]
8. Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors.
Daniëls LA; Krol SD; de Graaf MA; Scholte AJ; van 't Veer MB; Putter H; de Roos A; Schalij MJ; van de Poll-Franse LV; Creutzberg CL
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):164-71. PubMed ID: 25195991
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation.
Chen MH; Blackington LH; Zhou J; Chu TF; Gauvreau K; Marcus KJ; Fisher DC; Diller LR; Ng AK
Leuk Lymphoma; 2014 Nov; 55(11):2477-83. PubMed ID: 24397615
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
11. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.
van Nimwegen FA; Schaapveld M; Cutter DJ; Janus CP; Krol AD; Hauptmann M; Kooijman K; Roesink J; van der Maazen R; Darby SC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2016 Jan; 34(3):235-43. PubMed ID: 26573075
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
13. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
Aleman BM; van Leeuwen FE
Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
van Leeuwen FE; Ng AK
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors.
Lu Z; Teng Y; Ning X; Wang H; Feng W; Ou C
Cancer; 2022 Sep; 128(18):3330-3339. PubMed ID: 35872619
[TBL] [Abstract][Full Text] [Related]
16. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
[TBL] [Abstract][Full Text] [Related]
17. Radiation Therapy for Treatment of Adolescent and Young Adult Hodgkin Lymphoma and Risk for Cardiovascular Disease and Cancer.
Rugbjerg K; Olsen JH
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):1-8. PubMed ID: 30192163
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
[TBL] [Abstract][Full Text] [Related]
20. [Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma].
Fosså SD; Holte H; Holmen MM; Bjøro T; Langmark F; Hess SL; Kvaløy S
Tidsskr Nor Laegeforen; 2005 Jan; 125(1):41-4. PubMed ID: 15643464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
